by Jessica Casebolt | Sep 11, 2023 | Opioid/Substance Use Disorders, Tea Leaves
The Duke-Margolis Center for Health Policy, along with Third Horizon Strategies, launched a project funded by Elevance Health Foundation, to develop resources to guide state, county, and municipal investments of opioid settlement resources for their communities. The...
by Jessica Casebolt | Sep 11, 2023 | Opioid/Substance Use Disorders, Tea Leaves
Marijuana, hallucinogen use, and binge drinking reached historic highs among adults ages 35-50, according to a new study released Thursday. In the 2022 annual study of substance use behavior and attitudes, funded by the National Institute on Drug Abuse (NIDA), adults...
by Jessica Casebolt | Sep 11, 2023 | Opioid/Substance Use Disorders, Tea Leaves
According to a new survey conducted by KFF, a health policy research group, less than half of those with a substance use disorder have received treatment. The survey, which polled more than 1,300 adults in July, underscores the broad and often harmful influence of...
by Jessica Casebolt | Sep 11, 2023 | Opioid/Substance Use Disorders, Tea Leaves
As states and counties spend the first wave of opioid settlement dollars from the pharmaceutical industry, public health groups are challenging how some funds are being used. In some states, law enforcement departments receive opioid settlement money for policing...
by Jessica Casebolt | Sep 11, 2023 | Opioid/Substance Use Disorders, Tea Leaves
Researchers say that access to SUD care for Medicaid fee-for-service beneficiaries has improved from 2014 until 2021. Some of the improvements that have occurred are related to offering outpatient treatment and detoxification and a decrease in prior authorizations and...
by Jessica Casebolt | Sep 11, 2023 | Opioid/Substance Use Disorders, Tea Leaves
The Supreme Court on Thursday froze a bankruptcy reorganization plan for OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from civil claims in exchange for paying up to $6 billion to address the U.S. opioid...
Recent Comments